IVERMED
Live / Registered — Registered (as of 21 May 2024)
What this means for you
Registered since 21 May 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97319437
- Registration number
- 7392450
- Mark type
- Stylized text
- Filed
- 18 Mar 2022
- Published for opposition
- 25 Jul 2023
- Registered
- 21 May 2024
- Attorney of record
- Ashley D. Johnson
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical compositions and medicaments for use in treatment of cancer; Pharmaceutical compositions and medicaments for use in treatment of a disease or condition in a subject, namely, inhibiting the proliferation, metastasis and angiogenic activity of malignant cells; Pharmaceutical compositions and medicaments for use in treatment of a disease or condition in a subject, namely, regulation of one or more kinase signaling pathway, reversing multi-drug resistance, inhibiting tumor stem cells; Pharmaceutical compositions and medicaments for use in treatment of a disease or condition in a subject, namely, providing anti-inflammatory and antiviral properties; Pharmaceutical compositions and medicaments for use in the treatment of cancer
Owner
- Right2Try Inc., Lewes, DE, US
- Right2Try Inc., Lewes, DE, US
- Right2Try Inc., Lewes, DE, US
Prosecution history
- 21 May 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 21 May 2024 — REGISTERED-PRINCIPAL REGISTER
- 12 Apr 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 11 Apr 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 04 Mar 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 12 Feb 2024 — USE AMENDMENT FILED
- 04 Mar 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 Feb 2024 — TEAS STATEMENT OF USE RECEIVED
- 19 Sept 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 25 Jul 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Jul 2023 — PUBLISHED FOR OPPOSITION
- 05 Jul 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 Jun 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Jun 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 08 Jun 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE